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Phorbol I2-myristate- I3-acetate (PMA) is shown to induce spermidine/spermine N’-acetyltransferase, a 
rate-limiting enzyme of polyamine biodegradation, in bovine lymphocytes. When PMA and phytohemag- 
glutinin (PHA) were added simultaneously, the enzyme activity was stimulated synergistically. The ability 
of phorbol esters to stimulate the enzyme activity was consistent with their tumor-promoting ability. Phor- 
bol, which is not a tumor promotor, was incapable of stimulating the enzyme activity. Phorbol diacetate 
weakly stimulated the activity of the acetylase. Phorbol dibutyrate had a similar stimulatory effect to PMA. 
These results suggest that the spermidine/spermine N’-acetyltransferase may play an important role in 
changes in polyamine l vels in phorbol ester-treated cells and that the increase in the enzyme activity may 
have some relationship to the control of cell growth and differentiation by phorbol esters. 
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1. INTRODUCTION 
Phorbol 12-myristate-13-acetate (PMA) and 
related phorbol diesters, which are plant 
diterpenes, promote the formation of skin tumors 
after initiation by a low dose of a carcinogen [l]. 
Studies on the effects of tumor-promoting phorbol 
esters in several cells have revealed that the induc- 
tion of ornithine decarboxylase and the subsequent 
accumulation of polyamines is one of the earliest 
and most pronounced responses of cells to tumor 
promotors [2-41. Authors in [2,3] suggested that 
the alterations in polyamine metabolism could be 
an essential if not sufficient component of the 
2-stage mechanism of tumor promotion. 
dent rather than related events [5,6]. Authors in [7] 
also indicated that promotor-induced changes in 
polyamine levels can occur without alterations of 
activities of ornithine decarboxylase and S- 
adenosylmethionine decarboxylase which are rate- 
limiting enzymes of polyamine biosynthesis in the 
PMA-treated human myeloid leukemia cell line 
HL-60. 
Therefore, the mechanism of alterations in 
polyamine metabolism is not clear. Here, we in- 
vestigated the effect of phorbol esters on sper- 
midine/spermine N’-acetyltransferase, which is a 
rate-limiting enzyme of polyamine biodegradation, 
in bovine lymphocytes stimulated with mitogen 
(PHA), PMA or both. 
However, some reports have demonstrated that 
promotor-mediated cellular hyperplasia and or- 
nithine decarboxylase induction could be indepen- 
2. MATERIALS AND METHODS 
2.1. Reagents 
* Present address: Department of Biochemistry, In- PMA was obtained from L.C. Service Corp., 
stitute of Clinical Medicine, Sino-Japan Friendship Woburn, MA. 4-Phorbol, phorbol 12,13-dia- 
Hospital, Peking, China cetate, phorbol 12,13-dibutyrate, cycloheximide 
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and actinomycin D were purchased from Sigma, 
St. Louis, MO. Phytohemagglutinin P was ob- 
tained from Difco, Detroit, ML Horse serum was 
obtained from Commonwealth Serum Labora- 
tories, Victoria, Australia. [acetyl-l-14C]Acetyl 
CoA (53.5 mCi/mmol) was from New England 
Nuclear, Boston, MA. 
2.2. Lymphocytes 
Bovine pharyngenous lymph nodes were kindly 
provided by Osaka City Meat Inspection 
Laboratory, Osaka. The lymphocytes were 
separated from other cells as in [8] and suspended 
in Eagle’s minimum essential medium containing 
1% (v/v) horse serum at a concentration of 1 x 10’ 
cells/ml. Three ml of the cells was cultured in a 
sterile glass Petri dish (45 mm) in a humidified at- 
mosphere of 5% CO2 in air at 37°C. The cells were 
preincubated overnight prior to the additions of 
PHA, PMA and other drugs. Stock solutions of 
phorbol esters were dissolved in dimethyl sulfoxide 
and kept at 4°C in the dark until use. The final 
dimethyl sulfoxide concentration in culture was 
always 0.5% or less. 
2.3. Assay of s~ermid~ne/spermi~e 
N’-acetyltra~sferase activity 
Preparation of enzyme solution from the cells 
has been described [9]. Spermidine/spermine 
N’-acetyltransferase was determined by following 
the incorporation of [acetyl-l-‘4C]acetyl CoA into 
monoacetylspermidine [9]. The incubation time 
was 10 min at 37°C. 
3. RESULTS 
When various concentrations of PMA were add- 
ed to the lymphocyte suspensions and the activity 
of spermidine/spermine ~‘-acetyltransferase deter- 
mined 24 h after the addition, the enzyme activity 
was found to increase in a dose-dependent manner 
as shown in fig.1. The enzyme activity had in- 
creased by 2.5-fold 24 h after the addition of PMA 
(50 ng/ml). The addition of PHA produced a 
similar or somewhat smaller increase, but the com- 
bined exposure to PMA and PHA resulted in a 
synergistic increase. The elevation of the enzyme 
was markedly reduced when cycloheximide or ac- 
tinomycin D was added to the cell culture 
simultaneously with PMA and/or PHA (not 
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Fig. 1. Effect of various concentrations of phorbol 
12-myristate-l3-acetate on spermidine/spermine N’- 
acetyltransferase activity. Bovine lymphocytes (10’ 
cells/ml) were treated with various concentrations of 
phorbol 12-myristate-13-acetate (PMA) and/or phyto- 
hemagglutinin (PHA) (5 pg/ml). Spermidine/spermine 
N’-acetyltransferase activity was measured as described 
previously. The results are the means f SE of 3 experi- 
ments. (0) PMA-treated cells, (m) PMA- and PHA- 
treated cells. 
shown). These results imply that new protein and 
RNA synthesis are required for the enhancement 
of spermidine/spermine ~I-acetyltransferase ac- 
tivity in bovine lymphocytes treated with PMA 
and/or PHA. 
The spermidine/spermine N’-acetyltransferase 
activity changed with time after addition of PMA 
or PHA as shown in fig.2. The enzyme activity in 
PMA-treated lymphocytes was induced biphasical- 
ly having peaks at 24 and 48 h after the addition, 
whereas that of PHA-stimulated lymphocytes 
gradually increased and reached its maximum at 
40 h. In the cells treated with the combination of 
PMA and PHA, the enzyme activity peaked at 24 
and 48 h after the addition of inducers. 
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Fig.2. Effect of phorbol 12-myristate-13-acetate and 
phytohemagglutinin on spermidine/spermine N’-acetyl- 
transferase activity. Bovine lymphocytes (10’ cells/ml) 
were treated with phorbol 12-myristate-13-acetate 
(PMA) (50 ng/ml) and/or phytohemagglutinin (PHA) 
(5 pg/ml) and were harvested at the times shown. The 
results are the means + SE of 3 experiments. (0) PMA- 
treated cells, (A) PHA-treated cells, (0) PMA- and 
PHA-treated cells. 
Table 1 
Relative increase in the activity of spermidine/spermine 
N’-acetyltransferase following treatment with various 
phorbol compounds 
Treatment Spermidine/spermine 
N’-acetyltransferase 
activity (nmol/mg protein 
per 10 min) 
Control 
PHA 
PHA + phorbol 
PHA + 
phorbol 12,13-diacetate 
PHA + 
phorbol 12,13-dibutyrate 
PHA + phorbol 
12-myristate-13-acetate 
0.18 f 0.03 
0.24 + 0.02 
0.25 f 0.03 
0.43 f 0.03 
1.07 + 0.03 
1.00 + 0.08 
Bovine lymphocytes (10’ cells/ml) were treated with 
various phorbol compounds (50 ng/ml) and/or 
phytohemagglutinin (PHA) (5 pg/ml) and were 
harvested 24 h later. The results are the means + SE of 
3 experiments 
The relative ability of a series of phorbol esters 
to stimulate spermidine/spermine iV’-acetyltrans- 
ferase activity was investigated. Phorbol esters 
having tumor-promoting activity in mouse skin 
were also capable of stimulating the enzyme activi- 
ty. A non-promotor, a phorbol, was incapable of 
stimulating the enzyme activity. Phorbol diacetate 
weakly stimulated the activity of the acetylase. 
Phorbol dibutyrate had a stimulatory effect similar 
to that of PMA (table 1). Thus the structural re- 
quirements of the phorbol diterpenes for tumor 
promotion are similar to those for the stimulation 
of spermidine/spermine iV’-acetyltransferase 
activity. 
4. DISCUSSION 
The physiologically occurring polyamines, 
putrescine, spermidine and spermine, have been 
shown to be involved in the regulation of cell 
growth and in tumor promotion [lo]. 
When applied to mouse epidermis or cultured 
cells, PMA induces many phenotypic changes 
which are associated with the transformed state 
[6]. One of this series of changes is the induction 
of ornithine decarboxylase with the subsequent in- 
crease in polyamine levels and cellular prolifera- 
tion [3]. However, some reports indicated that 
promotor-mediated cellular hyperplasia and or- 
nithine decarboxylase induction could be indepen- 
dent rather than related events [5,6]. Glucocor- 
ticoids, which inhibit tumor promotion, failed to 
inhibit the PMA-mediated induction of ornithine 
decarboxylase [l 11. Authors in [7] also indicated 
that treatment of HL-60 cells with PMA or phor- 
bol 12,13_didecanoate r sulted in increased levels 
of putrescine without alterations in ornithine 
decarboxylase activity, suggesting the existence of 
an alternative pathway for putrescine formation 
which might be involved in the control of cell 
growth and differentiation in HL-60 cells. 
The mechanism of degradation of spermidine 
and spermine into putrescine has been established 
and shown to involve the sequential action of two 
enzymes, spermidine/spermine Nr-acetyltrans- 
ferase and polyamine oxidase [ 12-191. We have 
demonstrated that there is a large increase in the 
activity of spermidine/spermine Nl-acetyltrans- 
ferase in rat liver [12] and kidney [16], bovine lym- 
phocytes [9] and rabbit costal chondrocytes [20] 
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after exposure to a number of stimuli and that this 
enzyme is a rate-limiting enzyme in this acetyl- 
ase/oxidase pathway for interconversion of the 
polyamines [15,17]. 
The present results demonstrate that PMA in- 
duced the spermidine/spermine N’-acetyltrans- 
ferase activity in bovine lymphocytes. When PMA 
and PHA were added to the lymphocyte suspen- 
sions simultaneously, the enzyme activity increased 
synergistically. Furthermore, only phorbol ester 
derivatives which were capable of promoting the 
formation of tumors in the mouse skin system led 
to the stimulation of spermidine/spermine I$- 
acetyltransferase activity. In preliminary ex- 
periments, we measured the intracellular levels of 
polyamines in PMA- and/or PHA-treated bovine 
lymphocytes. The level of putrescine was increased 
and the levels of spermine and spermidine were 
decreased when spermidine/spermine N’-acetyl- 
transferase activity increased. These results suggest 
that the increase in the acetylase activity may have 
some relationship to the control of cell growth and 
differentiation by phorbol esters. 
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